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Introduction: Although coronary atherosclerosis is associ-
ated with calcific aortic valve disease (CAVD), it is not known
whether they share pathophysiological mechanisms in early
disease.
Aims: To investigate the relationship between myocardial
blood flow reserve (MBFR) - a measure of coronary micro-
circulatory function, and early CAVD. We also determined
whether this relationship was independent of coronary artery
disease (CAD) and hs-CRP, a marker of systemic inflamma-
tion.
Methods & Results: 183 patients with chest pain and unob-
structed coronary arteries were recruited. AVCS, coronary
total plaque length (TPL), and coronary calcium score were
quantified from multislice CT. MBFR was assessed using
vasodilator myocardial contrast echocardiography. Inflam-
matory markers were obtained from venous sampling.
Mean age was 59.8 years, with 52.5% being male. The
mean AVCS was 68AU (SD 258). Mean TPL was 15.6mm,
and median coronary calcification score was 43.5AU. The
mean MBFR was 2.20 (SD 0.52). Mean hs-CRP was 2.52mg/L
(SD 3.86), with 59% participants having normal hs-CRP
levels. Multivariate linear regression modelling incorporat-
ing demographics, coronary plaque characteristics, MBFR,
and inflammatory markers, demonstrated that age (=+0.05,
CI:+0.02,+0.08, P=0.007), hs-CRP (=+0.09, CI:+0.02,+0.16,
P=0.010) and presence of diabetes (=+1.03, CI:+0.08,+1.98,
P=0.033), were positively associated with AVCS. In contrast,
MBFR (=-0.87, CI:-1.44,-0.30, P=0.003), body mass index
(=-0.11, CI:-0.21,-0.01, P=0.033), and LDL cholesterol (=-
0.32, CI:-0.61,-0.03, P=0.029) were negatively associated with
AVCS. TPL and coronary calcium score became insignificant
when included in multivariate analysis.
Conclusions: MBFR is an independent predictor of aor-
tic valve calcification and this effect is independent of the
presence of CAD and also systemic inflammation.
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Introduction: Ironman athletes can develop right ven-
tricular dysfunction predisposing them to sudden cardiac
death. In this novel stress echocardiography study, we sought
to characterise ironman athletes’ transpulmonary haemody-
namics at extreme workloads (>20METs) compared with a
non-athlete population using the novel echocardiographic
parameter, ePLAR (“echocardiographic Pulmonary to Left
Atrial Ratio” = TRVmax/mitralE/e’)
Method: 19 athletes (age 38.3±10 years; 84% male) under-
went treadmill stress echo including haemodynamic data
(TRVmax, E/e’ ratio and ePLAR) at rest and within 60 seconds
of exercise cessation. Athletes were compared to 181 non-
athletes (age 66±10 years)
Results: The athletes achieved 20.7±1.6METs vs.
9.9±3.2METs in non-athletes. No statistical difference
was seen in resting TRVmax (2.4±0.17m/s vs. 2.4±0.3m/s)
and mitral E velocities (0.82±0.14 vs. 0.74±0.21) between
athletes and non-athletes. However, resting e’ velocities
were significantly higher in athletes (0.11±0.02m/s vs.
0.08±0.03m/s, p«<0.0001), resulting in statistically different
ePLAR values between the two groups (0.33±0.06m/s
vs. 0.27±0.09m/s, p<0.01). At peak exercise, there was a
substantial increase in TRVmax in athletes (3.81±0.54m/s
vs. 3.19±0.49m/s, p«<0.0001) resulting in significant rise in
ePLAR (0.47±0.13m/s vs. 0.34±0.11, p«<0.0001) consistent
with a marked increase in transpulmonary gradient
Conclusion: RVSP and transpulmonary gradient (esti-
mated by ePLAR) increase with exercise and are significantly
exaggerated in ironman athletes compared to the non-athlete
population suggesting a possible physiologic mechanism for
RV systolic dysfunction in the long-term endurance athletes.
http://dx.doi.org/10.1016/j.hlc.2016.06.566
